サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1576516

止血剤の市場規模、シェア、予測、動向分析：タイプ別・用途別・エンドユーザー別 - 2031年までの世界の予測

Hemostats Market Size, Share, Forecast, & Trends Analysis by Type Form Application End User - Global Forecast to 2031

出版日
ページ情報
英文 280 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.32円
止血剤の市場規模、シェア、予測、動向分析：タイプ別・用途別・エンドユーザー別 - 2031年までの世界の予測
出版日: 2024年08月01日
発行: Meticulous Research
ページ情報: 英文 280 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

止血剤市場は、2024年から2031年にかけてCAGR 6.9％で2031年までに53億2,000万米ドルに達すると予測されます。

本レポートは、広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、主要な市場促進要因、抑制要因、課題、機会の分析から構成されています。この市場の成長は、がん、心血管疾患、整形外科疾患、神経疾患などの慢性疾患の有病率の上昇とそれに伴う外科手術量の増加、事故率の上昇、帝王切開分娩数の増加、致命的な怪我、臓器移植、研究開発活動の増加、医療費の増加、低侵襲外科手術への嗜好の高まりなどに起因しています。しかし、止血剤に使用される材料によるアレルギー反応がこの市場の成長を抑制しています。

さらに、高度な止血剤の使用の増加、歯科用止血剤の進歩、装填済み塗布器やRTU止血剤の需要の増加は、この市場で事業を展開する企業に成長機会をもたらすと期待されています。しかし、止血剤の製造コストが高いことや、高度な抗菌止血剤のコストが高いことが、市場成長に影響を与える大きな課題です。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場成長の要因

  • 概要
  • 促進要因
    • 手術件数の増加
    • 手術機器分野における研究開発の活発化
    • 事故率の増加
    • 帝王切開分娩、死亡事故、臓器移植の増加
    • 政府機関・民間企業による研究開発活動の増加
    • 政府の医療費支出の増加
    • 低侵襲手術の採用拡大
  • 抑制要因
    • 止血剤の材料によるアレルギー反応
  • 機会
    • 高度な止血剤の使用による出血量制御ニーズの高まり
    • 歯科用止血剤の進歩
    • 装填済み塗布器とRTU (Ready-to-Use) 止血剤の需要の増加
  • 課題
    • 止血剤の製造コストの高さ
    • 高度抗菌止血剤のコスト高
  • 動向
    • バイオポリマーベース止血剤
    • デュアルアクション止血剤技術
  • 要因分析
  • 規制分析
  • 価格分析
  • ケーススタディ
  • ポーターのファイブフォース分析

第5章 止血剤市場の評価：タイプ別

  • 概要
  • 吸収性止血剤
    • 機械的・受動的止血剤
      • ゼラチンベース止血剤
      • コラーゲン止血剤
      • 酸化再生セルロース止血剤
    • フロワブル剤・活性剤
      • トロンビン系止血剤
      • コンビネーション止血剤
    • その他の吸収性止血剤
  • 非吸収性止血剤
    • フィブリンシーラント
    • 合成シーラント
    • 止血ガーゼ
    • 止血鉗子

第6章 止血剤市場の評価：用途別

  • 概要
  • 外科
    • 整形外科
    • 一般外科
    • 婦人科外科
    • 心血管外科
    • 脳神経外科
    • 形成外科
    • その他の外科
  • 歯科治療
  • 外傷

第7章 止血剤市場の評価：形状別

  • 概要
  • スポンジ・ドレッシング
  • シート・パッド
  • 粉末
  • マトリックス・ゲル
  • ツール

第8章 止血剤市場の評価：エンドユーザー別

  • 概要
  • 病院・診療所
  • 外来手術センター
  • 介護施設

第9章 止血剤市場の評価：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • スイス
    • オランダ
    • その他欧州（RoE）
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋（RoAPAC）
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ（RoLATAM）
  • 中東・アフリカ

第10章 競合分析

  • 概要
  • 主要成長戦略
  • 競合ベンチマーキング
  • 競合ダッシュボード
    • 業界リーダー
    • 市場差別化要因
    • 前衛的企業
    • 新興企業
  • 主要企業の市場シェア分析/市場ランキング（2023年）

第11章 企業プロファイル（事業概要、財務概要、製品ポートフォリオ、戦略展開状況）

  • Baxter International Inc.（米国）
  • Pfizer Inc.（米国）
  • B. Braun Melsungen AG（ドイツ）
  • C. R. Bard, Inc.（米国）
  • Integra LifeSciences（米国）
  • Medtronic plc（Ireland）
  • CSL Behring（英国）
  • Gelita Medical GmbH（ドイツ）
  • Grifols, S.A.（Spain）
  • Abbott Laboratories（米国）
  • CryoLife（米国）
  • Ethicon, Inc.（米国）（Johnson & Johnsonの子会社）
  • Medtronic plc（アイルランド）
  • Becton, Dickinson and Company（BD）（米国）
  • Advanced Medical Solutions Group plc（英国）

（注：上位5社のSWOT分析を掲載）

第12章 付録

図表

LIST OF TABLES

  • Table 1 Global Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 2 Global Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 3 Global Absorbable Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 5 Global Mechanical or Passive Hemostatic Agents Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global Gelatin-based Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 7 Global Collagen Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global Oxidized Regenerated Cellulose Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 10 Global Flowable and Active Hemostatic Agents Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Thrombin-based Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 12 Global Combination Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 13 Global Other Absorbable Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 15 Global Non-absorbable Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Fibrin Sealants Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Synthetic Sealants Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Hemostatic Gauze Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Hemostatic Forceps Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 21 Global Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 22 Global Hemostats Market Size for Surgery, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Hemostats Market Size for Orthopedic Surgery, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Global Hemostats Market Size for General Surgery, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Global Hemostats Market Size for Gynecology Surgery, by Country/Region, 2022-2031 (USD Million)
  • Table 26 Global Hemostats Market Size for Cardiovascular Surgery, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global Hemostats Market Size for Neurosurgery, by Country/Region, 2022-2031 (USD Million)
  • Table 28 Global Hemostats Market Size for Plastic Surgery, by Country/Region, 2022-2031 (USD Million)
  • Table 29 Global Hemostats Market Size for Other Surgeries, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Global Hemostats Market Size for Dental Treatments, by Country/Region, 2022-2031 (USD Million)
  • Table 31 Global Hemostats Market Size for Traumatic Injury, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 33 Global Hemostatic Sponges and Dressings Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Global Hemostatic Sheets and Pads Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 35 Global Hemostatic Powders Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global Hemostatic Matrix and Gels Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Global Hemostatic Tools Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 38 Global Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 39 Global Hemostats Market Size for Hospitals & Clinics, by Country/Region, 2022-2031 (USD Million)
  • Table 40 Global Hemostats Market Size for Ambulatory Surgical Centers, by Country/Region, 2022-2031 (USD Million)
  • Table 41 Global Hemostats Market Size for Nursing Homes, by Country/Region, 2022-2031 (USD Million)
  • Table 42 Global Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 43 North America: Hemostats Market Size, by Country, 2022-2031 (USD Million)
  • Table 44 North America: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 45 North America: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 46 North America: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 47 North America: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 48 North America: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 49 North America: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 50 North America: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 51 North America: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 52 North America: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 53 U.S.: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 54 U.S.: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 55 U.S.: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 56 U.S.: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 57 U.S.: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 58 U.S.: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 59 U.S.: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 60 U.S.: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 61 U.S.: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 62 Canada: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 63 Canada: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 64 Canada: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 65 Canada: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 66 Canada: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 67 Canada: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 68 Canada: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 69 Canada: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 70 Canada: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 71 Europe: Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 72 Europe: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 73 Europe: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 74 Europe: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 75 Europe: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 76 Europe: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 77 Europe: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 78 Europe: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 79 Europe: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 80 Europe: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 81 Germany: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 82 Germany: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 83 Germany: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 84 Germany: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 85 Germany: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 86 Germany: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 87 Germany: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 88 Germany: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 89 Germany: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 90 France: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 91 France: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 92 France: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 93 France: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 94 France: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 95 France: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 96 France: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 97 France: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 98 France: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 99 U.K.: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 100 U.K.: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 101 U.K.: Mechanical or Passive Hemostats Agentic Market Size, by Type, 2022-2031 (USD Million)
  • Table 102 U.K.: Flowable and Active Hemostats Agentic Market Size, by Type, 2022-2031 (USD Million)
  • Table 103 U.K.: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 104 U.K.: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 105 U.K.: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 106 U.K.: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 107 U.K.: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 108 Italy: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 109 Italy: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 110 Italy: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 111 Italy: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 112 Italy: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 113 Italy: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 114 Italy: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 115 Italy: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 116 Italy: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 117 Spain: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 118 Spain: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 119 Spain: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 120 Spain: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 121 Spain: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 122 Spain: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 123 Spain: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 124 Spain: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 125 Spain: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 126 Netherlands: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 127 Netherlands: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 128 Netherlands: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 129 Netherlands: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 130 Netherlands: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 131 Netherlands: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 132 Netherlands: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 133 Netherlands: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 134 Netherlands: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 135 Switzerland: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 136 Switzerland: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 137 Switzerland: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 138 Switzerland: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 139 Switzerland: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 140 Switzerland: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 141 Switzerland: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 142 Switzerland: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 143 Switzerland: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 144 Rest of Europe (RoE): Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 145 Rest of Europe (RoE): Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 146 Rest of Europe (RoE): Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 147 Rest of Europe (RoE): Flowable and Active Hemostats Agentic Market Size, by Type, 2022-2031 (USD Million)
  • Table 148 Rest of Europe (RoE): Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 149 Rest of Europe (RoE): Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 150 Rest of Europe (RoE): Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 151 Rest of Europe (RoE): Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 152 Rest of Europe (RoE): Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 153 Asia-Pacific: Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 154 Asia-Pacific: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 155 Asia-Pacific: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 156 Asia-Pacific: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 157 Asia-Pacific: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 158 Asia-Pacific: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 159 Asia-Pacific: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 160 Asia-Pacific: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 161 Asia-Pacific: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 162 Asia-Pacific: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 163 Japan: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 164 Japan: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 165 Japan: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 166 Japan: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 167 Japan: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 168 Japan: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 169 Japan: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 170 Japan: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 171 Japan: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 172 China: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 173 China: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 174 China: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 175 China: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 176 China: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 177 China: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 178 China: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 179 China: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 180 China: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 181 India: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 182 India: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 183 India: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 184 India: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 185 India: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 186 India: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 187 India: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 188 India: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 189 India: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 190 Australia: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 191 Australia: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 192 Australia: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 193 Australia: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 194 Australia: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 195 Australia: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 196 Australia: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 197 Australia: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 198 Australia: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 199 South Korea: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 200 South Korea: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 201 South Korea: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 202 South Korea: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 203 South Korea: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 204 South Korea: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 205 South Korea: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 206 South Korea: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 207 South Korea: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 208 Rest of Asia-Pacific (RoAPAC): Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 209 Rest of Asia-Pacific (RoAPAC): Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 210 Rest of Asia-Pacific (RoAPAC): Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 211 Rest of Asia-Pacific (RoAPAC): Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 212 Rest of Asia-Pacific (RoAPAC): Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 213 Rest of Asia-Pacific (RoAPAC): Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 214 Rest of Asia-Pacific (RoAPAC): Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 215 Rest of Asia-Pacific (RoAPAC): Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 216 Rest of Asia-Pacific (RoAPAC): Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 217 Latin America: Hemostats Market Size, by Country/Region, 2022-2031 (USD Million)
  • Table 218 Latin America: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 219 Latin America: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 220 Latin America: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 221 Latin America: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 222 Latin America: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 223 Latin America: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 224 Latin America: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 225 Latin America: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 226 Latin America: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 227 Brazil: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 228 Brazil: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 229 Brazil: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 230 Brazil: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 231 Brazil: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 232 Brazil: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 233 Brazil: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 234 Brazil: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 235 Brazil: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 236 Mexico: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 237 Mexico: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 238 Mexico: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 239 Mexico: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 240 Mexico: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 241 Mexico: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 242 Mexico: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 243 Mexico: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 244 Mexico: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 245 Rest of Latin America (RoLA): Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 246 Rest of Latin America (RoLA): Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 247 Rest of Latin America (RoLA): Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 248 Rest of Latin America (RoLA): Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 249 Rest of Latin America (RoLA): Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 250 Rest of Latin America (RoLA): Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 251 Rest of Latin America (RoLA): Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 252 Rest of Latin America (RoLA): Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 253 Rest of Latin America (RoLA): Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 254 Middle East & Africa: Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 255 Middle East & Africa: Absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 256 Middle East & Africa: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 257 Middle East & Africa: Flowable and Active Hemostatic Agents Market Size, by Type, 2022-2031 (USD Million)
  • Table 258 Middle East & Africa: Non-absorbable Hemostats Market Size, by Type, 2022-2031 (USD Million)
  • Table 259 Middle East & Africa: Hemostats Market Size, by Application, 2022-2031 (USD Million)
  • Table 260 Middle East & Africa: Hemostats Market Size for Surgery, by Type, 2022-2031 (USD Million)
  • Table 261 Middle East & Africa: Hemostats Market Size, by Form, 2022-2031 (USD Million)
  • Table 262 Middle East & Africa: Hemostats Market Size, by End User, 2022-2031 (USD Million)
  • Table 263 Recent Developments, by Company, 2020-2024

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Size Estimation Approach
  • Figure 7 Global Hemostats Market, by Type, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Hemostats Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Hemostats Market, by Form, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global Hemostats Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 11 Global Hemostats Market, by Geography
  • Figure 12 Impact Analysis: Hemostats Market
  • Figure 13 Global Hemostats Market, by Type, 2024 Vs. 2031 (USD Million)
  • Figure 14 Global Hemostats Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 15 Global Hemostats Market, by Form, 2024 Vs. 2031 (USD Million)
  • Figure 16 Global Hemostats Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 17 Global Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 18 North America: Hemostats Market Snapshot
  • Figure 19 Europe: Hemostats Market Snapshot
  • Figure 20 Asia-Pacific: Hemostats Market Snapshot
  • Figure 21 Latin America: Hemostats Market Snapshot
  • Figure 22 Key Growth Strategies Adopted by Leading Players (2020-2024)
  • Figure 23 Global Hemostats Market: Competitive Benchmarking, by Product
  • Figure 24 Global Hemostats Market: Competitive Benchmarking, by Geography
  • Figure 25 Global Hemostats Market: Vendor Dashboard
  • Figure 26 Global Hemostats Market: Market Share Analysis (2024)
  • Figure 27 Baxter International Inc.: Financial Overview (2024)
  • Figure 28 Pfizer Inc.: Financial Overview (2024)
  • Figure 29 B. Braun Melsungen AG: Financial Overview (2024)
  • Figure 30 Integra LifeSciences: Financial Overview (2024)
  • Figure 31 Medtronic plc: Financial Overview (2024)
  • Figure 32 CSL Behring: Financial Overview (2024)
  • Figure 33 Gelita Medical GmbH: Financial Overview (2024)
  • Figure 34 Grifols, S.A.: Financial Overview (2024)
  • Figure 35 Abbott Laboratories, Inc.: Financial Overview (2024)
  • Figure 36 CryoLife, Inc.: Financial Overview (2024)
  • Figure 37 Ethicon, Inc. (U.S.) (Subsidiary of Johnson & Johnson): Financial Overview (2024)
  • Figure 38 Becton, Dickinson and Company (BD): Financial Overview (2024)
  • Figure 39 Advanced Medical Solutions Group plc: Financial Overview (2024)
目次
Product Code: MRHC - 1041150

Hemostats Market Size, Share, Forecast, & Trends Analysis by Type (Gelatin, Collagen, Thrombin, Fibrin, Synthetic Sealant, Gauze) Form (Sheet, Powder, Gel) Application (Orthopedic, General, Cardiovascular, Dental, Trauma) End User- Global Forecast to 2031

The hemostat market is projected to reach $5.32 billion by 2031 at a CAGR of 6.9% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market can be attributed to the increasing prevalence of chronic diseases such as cancer, cardiovascular, orthopedic, and neurological diseases and subsequent increase in the volume of surgical procedures; increasing rate of accidents; rise in the number of cesarean deliveries, fatal injuries, and organ transplantation; increased R&D activities; rising healthcare spending; and growing preference for minimally invasive surgical procedures. However, allergic reactions caused by the material used in making hemostats restrain the growth of this market.

Furthermore, the increasing use of advanced hemostats, advancements in dental hemostatic agents, and increasing demand for preloaded applicators and ready-to-use hemostats are expected to generate growth opportunities for the players operating in this market. However, the high manufacturing cost for hemostasis and the high cost of advanced antimicrobial hemostatic agents are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the hemostat market are Baxter International Inc. (U.S.), Pfizer Inc. (U.S.), B. Braun Melsungen AG (Germany), C. R. Bard, Inc.(U.S.), Integra LifeSciences (U.S.), Medtronic plc (Ireland), CSL Behring (U.K.), Gelita Medical GmbH (Germany), Grifols, S.A. (Spain), Abbott Laboratories (U.S.), CryoLife (U.S.), Ethicon, Inc. (U.S.) (Subsidiary of Johnson & Johnson.), Medtronic plc (Ireland), Becton, Dickinson and Company (BD) (U.S.), and Advanced Medical Solutions Group plc (U.K.).

Among all the types studied in this report, in 2024, the absorbable hemostats segment is expected to account for the largest share of 58.6% of the hemostat market. The segment's large share is attributed to the advantages offered by absorbable hemostats, such as controlling bleeding from fistula-puncture sites, achieving hemostasis during vascular surgery, controlling capillary bleeding, availability of versatile forms of hemostats, and rapid embolization.

Among all the applications studied in this report, in 2024, the surgery segment is expected to account for the larger share of the hemostat market. The largest market share of this segment is attributed to the increasing number of surgeries, rise in the number of accidents, and growing demand for cosmetic/plastic surgeries. For instance, according to the World Health Organization (WHO), in 2021, yearly, 4.4 million people died from injuries, 3.16 million died from accidental wounds, and 1.25 million died from violence-related injuries globally.

Among all the forms studied in this report, in 2024, the matrix and gel segment is expected to account for the largest share of the hemostat market. The segment's large share is attributed to advantages offered by matrix and gel hemostatic agents, such as the formation of a physical matrix, promoting activation of the clotting pathway; their wide applications in patients with intact coagulation cascade; availability of bioactive and biocompatible gels; and cost efficiency.

Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the hemostat market. The growing number of surgeries conducted in hospitals, the use of hemostats for control of minor, moderate, and severe bleeding in operating rooms, the availability of different forms of hemostats used for surgical procedures, and the availability of favorable reimbursement policies are some of the major factors driving the growth of this segment.

An in-depth analysis of the geographical scenario of the hemostat market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of 32.9% of the hemostat market. In the region in 2024, the U.S. is expected to account for the largest share of the hemostat market in North America. The large share of this regional market is attributed to the presence of key market players in the U.S., a well-established and technologically advanced healthcare infrastructure, and favorable government policies in the country.

Scope of the Report:

Hemostat Market Assessment-by Type

  • Absorbable Hemostats
    • Mechanical or Passive Agents
  • Gelatin-based Hemostat
  • Collagen Hemostat
  • Oxidized Regenerated Cellulose Hemostat
    • Flowable and Active Agents
  • Thrombin-based Hemostat
  • Combination Hemostat
    • Other Absorbable Hemostat
  • Non-absorbable Hemostats
    • Fibrin Sealants
    • Synthetic Sealants
    • Hemostatic Gauze
    • Hemostatic Forceps

Hemostat Market Assessment-by Application

  • Surgery
    • Orthopedic Surgery
    • General Surgery
    • Gynecology Surgery
    • Cardiovascular Surgery
    • Neurosurgery
    • Plastic Surgery
    • Other Surgeries
  • Dental Treatments
  • Traumatic Injury

Hemostat Market Assessment-by Form

    • Sponges and Dressings
    • Sheets and Pads
    • Powder
    • Matrix and Gel
    • Tools

Hemostat Market Assessment-by End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Nursing Homes

Hemostat Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K
    • Italy
    • Spain
    • Switzerland
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Data Collection and Validation Process
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Factors Affecting Market Growth

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Volume of Surgical Procedures Performed
    • 4.2.2. High Research and Development in Surgical Devices Sector
    • 4.2.3. Increasing Rate of Accidents
    • 4.2.4. Increase in Cesarean Deliveries, Fatal Injuries, and Organ Transplantation
    • 4.2.5. Increasing R&D Activities by Government Organizations and the Private Sector
    • 4.2.6. Rising Government Healthcare Spending
    • 4.2.7. Growing Adoption of Minimally Invasive Surgical Procedures
  • 4.3. Restraints
    • 4.3.1. Allergic Reactions Caused by the Material Used in Making Hemostats
  • 4.4. Opportunities
    • 4.4.1. Increasing Need to Control Blood Loss by Using Advanced Hemostats
    • 4.4.2. Advancements in Dental Hemostatic Agents
    • 4.4.3. Increasing Demand for Preloaded Applicators and Ready-to-Use Hemostats
  • 4.5. Challenges
    • 4.5.1. High Manufacturing Cost for Hemostasis
    • 4.5.2. High Cost of Advanced Antimicrobial Hemostatic Agents
  • 4.6. Trends
    • 4.6.1. Biopolymer-based Hemostats
    • 4.6.2. Dual-Action Hemostatic Technology
  • 4.7. Factor Analysis
  • 4.8. Regulatory Analysis
  • 4.9. Pricing Analysis
  • 4.10. Case Studies
  • 4.11. Porter's Five Forces Analysis

5. Hemostats Market Assessment-by Type

  • 5.1. Overview
  • 5.2. Absorbable Hemostats
    • 5.2.1. Mechanical or Passive Agents
      • 5.2.1.1. Gelatin-based Hemostat
      • 5.2.1.2. Collagen Hemostat
      • 5.2.1.3. Oxidized Regenerated Cellulose Hemostat
    • 5.2.2. Flowable and Active Agents
      • 5.2.2.1. Thrombin-based Hemostat
      • 5.2.2.2. Combination Hemostat
    • 5.2.3. Other Absorbable Hemostats
  • 5.3. Non-absorbable Hemostats
    • 5.3.1. Fibrin Sealants
    • 5.3.2. Synthetic Sealants
    • 5.3.3. Hemostatic Gauze
    • 5.3.4. Hemostatic Forceps

6. Hemostats Market Assessment-by Application

  • 6.1. Overview
  • 6.2. Surgery
    • 6.2.1. Orthopedic Surgery
    • 6.2.2. General Surgery
    • 6.2.3. Gynecology Surgery
    • 6.2.4. Cardiovascular Surgery
    • 6.2.5. Neurosurgery
    • 6.2.6. Plastic Surgery
    • 6.2.7. Other Surgeries
  • 6.3. Dental Treatments
  • 6.4. Traumatic Injury

7. Hemostats Market Assessment-by Form

  • 7.1. Overview
  • 7.2. Sponges and Dressings
  • 7.3. Sheets and Pads
  • 7.4. Powder
  • 7.5. Matrix and Gel
  • 7.6. Tools

8. Hemostats Market Assessment-by End User

  • 8.1. Overview
  • 8.2. Hospitals & Clinics
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Nursing Homes

9. Hemostats Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Switzerland
    • 9.3.7. Netherlands
    • 9.3.8. Rest of Europe (RoE)
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5 South Korea
    • 9.4.6. Rest of Asia-Pacific (RoAPAC)
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America (RoLATAM)
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Share Analysis/Market Rankings of Key Players (2023)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 11.1. Baxter International Inc. (U.S.)
  • 11.2. Pfizer Inc. (U.S.)
  • 11.3. B. Braun Melsungen AG (Germany)
  • 11.4. C. R. Bard, Inc.(U.S.)
  • 11.5. Integra LifeSciences (U.S.)
  • 11.6. Medtronic plc (Ireland)
  • 11.7. CSL Behring (U.K.)
  • 11.8. Gelita Medical GmbH (Germany)
  • 11.9. Grifols, S.A. (Spain)
  • 11.10. Abbott Laboratories (U.S.)
  • 11.11. CryoLife (U.S.)
  • 11.12. Ethicon, Inc. (U.S.) (a subsidiary of Johnson & Johnson.)
  • 11.13. Medtronic plc (Ireland)
  • 11.14. Becton, Dickinson and Company (BD) (U.S.)
  • 11.15. Advanced Medical Solutions Group plc (U.K.)

(Note: SWOT analysis of the top 5 companies will be provided.)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports